A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Prostate Cancer Metastatic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Mount Vernon Hospital, Barnsley, United Kingdom

  • Addenbrookes, Cambridge, United Kingdom

  • Royal Devon University Hospital Trust, Exeter, United Kingdom

  • Royal Devon & Exeter Hospital, Exeter, United Kingdom

  • The Princess Alexandra Hospital, Harlow, United Kingdom

  • University College London Hospitals NHS Foundation Trust, London, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Barts Health NHS Trust, London, United Kingdom

  • North Middlesex Hospital, London, United Kingdom

  • Royal Free Hospital, London, United Kingdom

  • The James Cook University Hospital, Middlesbrough, United Kingdom

  • Churchill Hospital, Oxford, United Kingdom

  • Derriford Hospital, Plymouth, United Kingdom

  • Queen Alexandra Hospital, Portsmouth, United Kingdom

  • Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, United Kingdom

  • North Tees Health NHS Trust, Stockton-on-Tees, United Kingdom

  • The Royal Marsden Hospital, Sutton, United Kingdom

  • Kings Mill Hospital, Sutton in Ashfield, United Kingdom

Study leads
  • Louise Brown

    Study Director

    MRC CTU at UCL

  • Nick James

    Principal Investigator

    Institute of Cancer Research, United Kingdom